Bestselling author Don Winslow has spent a decade of his life writing about the War on Drugs. His latest book is “The Cartel,” a true-to-life epic about the past decade of the Mexican-American drug wars. Winslow will discuss his book.
A ballot measure has been introduced that would legalize marijuana for recreational use in Arizona. Carlos Alfaro, Arizona Political Director for the Marijuana Policy Project, will debate the measure with Seth Leibsohn, chair of the Arizonans for Responsible Drug Policy.
Brain tumor experts at Barrow Neurological Institute at Dignity Health St. Joseph’s Hospital and Medical Center have launched a revolutionary fast-track approach to cancer research. In partnership with The Ben & Catherine Ivy Foundation, the Translational Genomics Research Institute (TGen) and the Barbara Ann Karmanos Cancer Institute, the “Phase 0 Trials,” shorten the evaluation of drug therapies for brain tumors from an average of five years to only six months. Dr. Nader Sanai, director of the Barrow Brain Tumor Research Center, and Dr. Michael Berens, TGen’s Deputy Director for Research Resources, will discuss the new research method.
On January 13, 33 television stations in Phoenix, Tucson and Yuma and most of the state’s radio stations will air “Hooked: Tracking Heroin’s Hold on Arizona.” It’s a 30-minute show produced by advanced journalism students at Arizona State University’s Walter Cronkite School of Journalism and Mass Communication that details the growing problem of heroin abuse in our state. Art Brooks, president and chief executive officer of the Arizona Broadcasters Association, Jacquee Petchel, a Cronkite professor and Pulitzer Prize-winning investigative reporter and editor who oversaw the production of the program, and Doug Coleman, special agent in charge of the Phoenix Field Division of the Drug Enforcement Administration, will discuss the show and the heroin problem.
A new report shows that drug and alcohol use among Arizona’s eighth, tenth and twelfth graders is down over the past two years. The study by the Arizona Criminal Justice Commission also shows that more teens are getting marijuana from those with a medical marijuana card. Andy LeFevre of the commission will discuss the report.
Proposition 303 would allow a terminally ill patient, with a doctor’s recommendation, to try medicine and treatments that have not received full approval by the U.S. Food and Drug Administration. Paulina Morris, a supporter of the measure, and Joan Koerber-Walker, president and CEO of the Arizona Bioindustry Association, will discuss the pros and cons of the “Right to Try” initiative.
An experimental treatment for the Ebola virus has been developed by an Arizona State University researcher. Charles Arntzen will discuss his work on a tobacco-derived drug being used to treat two Ebola virus patients flown to the U.S. for treatment.
Researchers from Phoenix Children’s Hospital, TGen, and the University of Arizona College of Medicine are working on developing individualized drugs for children with cancer and other diseases, with the drugs based on their genetics. Dr. Robert Arceci is the Division Chief of Oncology at Phoenix Children’s Hospital, and he will talk about the research.
Researchers have found a way to use an old treatment to extend the life of prostate cancer patients. Men who received a chemotherapy drug lived nearly 58 months versus 44 months for those not receiving it. The Mayo Clinic in Arizona was one of the sites for clinical trials for the drug study. Dr. Alan Bryce of the Mayo Clinic will discuss the treatment.
Several changes are being considered for Arizona’s Medical Marijuana program, including the possible use of the drug for those suffering from Post-Traumatic Stress Disorder. Public input is being sought on the changes. Arizona Department of Health Services Director Will Humble will discuss the potential changes.
Arizona State University is teaming up with seven other research universities to form a new Science and Technology Center that will use x-ray lasers to image bioparticles, make molecular movies and help design new drugs. The BioXFEL Center will be based at the University at Buffalo and will focus on developing a new bio-imaging technique to analyze molecules at which drug molecules can be targeted. Regents’ Professor of Physics at ASU John Spence will serve as the center’s director of science. He will talk about the BioXFEL Center.
The Banner Alzheimer’s Institute in Phoenix is involved in a groundbreaking clinical trial to test an Alzheimer’s prevention drug on people who are genetically likely to get the disease. Learn more about the trial from the Institute’s director Dr. Pierre Tariot.
One week after Senate Bill 1070 was signed into law, a Pinal County sheriff’s deputy was shot while on patrol in the desert. He was shot, allegedly, by drug smugglers. However, questions have been raised about the validity of the shooting. Paul Rubin of the Phoenix New Times explains the latest developments in this story.
Voters will be deciding on a medical marijuana initiative this November. Proposition 203 would protect terminally or seriously ill patients from state prosecution for using limited amounts of marijuana on a doctor’s recommendation. The proposition contains many other provisions to regulate medical marijuana. Paul Charlton of Keep Arizona Drug Free and Joe Yuhas of the Arizona Medical Marijuana Policy Project will discuss the pros and cons of proposition 203.
Justice Michael Ryan recently retired from the state’s High Court after a judicial career that spans more than two decades. During that time, he presided over the criminal trial of former Governor Evan Mecham, the AzScam political corruption trial, and the Phoenix Suns drug case. Hear what Justice Ryan has to say about his career and the state of Arizona’s judiciary.
Is Mexico on the verge of becoming a “narco-state”? Recent news about drug cartels dismantling local governments suggests they’re power is growing.
Dr. Llewellyn Howell, an Emeritus Professor of International Management at the Thunderbird School of Global Management, shares his thoughts about how to address the growing power of Mexico’s drug cartels.
Guns heading south into Mexico and drugs coming north into the United States are key ingredients in a formula for violence at the Arizona-Mexico border. Federal agents from the Drug Enforcement Administration and the Bureau of Alcohol, Tobacco, Firearms and Explosives talk about what their agencies are doing to reduce the violence and criminal activities
Television stations across the state will participate in the simultaneous airing of the documentary Crystal Darkness. The film reveals the far-reaching problem of methamphetamine addiction. Sergeant Joel Tranter with the Phoenix Police Department joins us to talk about the documentary, the effects of meth use as well as the drug's relation to crime, and child abuse in Arizona.
Copper theft is becoming a bigger problem in Arizona as drug users sell the metal to get money for their fixes. Representative Jerry Weiers has sponsored a bill that aims to reduce the problem by requiring I.D. when selling copper and checks or money orders mailed to the seller instead of cash at time of sale. Weiers will talk about his bill.
Current law states that people convicted for the first or second time for drug possession or use get probation rather than jail or prison time. Prop 301 would amend current law so that a person who is convicted for the first or second time of personal possession or use of meth can be sentenced to a term in jail or prison. The change in the law would allow judges to use a jail term as a condition of probation to force meth users to comply with court mandated drug rehab.
The new Medicare prescription drug plan got off to a rocky start. David Mitchell, State Director for AARP and Tom Betlach, Deputy Director for AHCCCS join us to discuss the problems and what you can do about them.
This report on one of the most destructive drugs ever to affect society looks at law enforcement and the effects of meth use. Attorney General Terry Goddard joins HORIZON talk about efforts to curb the drug.
David Mitchell, the Arizona State Director of the AARP, and Tom Betlach of the Arizona Health Care Cost Containment System join us to discuss recent problems with the new Medicare Prescription Drug Plan.
sign up has started for the new Medicare prescription drug program. But choosing a plan can be daunting. Lupe Solis of AARP and Heather Daniel of the Foundation for Senior Living explain how to best choose a plan and how to get more information.